ANIX Anixa Biosciences Inc: institutional ownership and insider trading
71 funds reported holding $20.1M of Anixa Biosciences Inc in their latest 13F filings; in Q2 2026 funds net bought $658K, with 9 new positions and 6 funds selling out; over the last 12 months insiders bought $482K and sold $0 on the open market.
ANIX revenue and earnings
- Quarter ended Jul 31, 2026: revenue n/a, net income −$2.61M, EPS -0.08
- Quarter ended Apr 30, 2026: revenue n/a, net income −$2.52M, EPS -0.07
- Quarter ended Jan 31, 2026: revenue n/a, net income −$2.57M, EPS -0.08
- Quarter ended Oct 31, 2025: revenue n/a, net income −$2.70M, EPS -0.08
Famous investors holding ANIX
- Renaissance Technologies (Renaissance Technologies): $166K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $89.3K, 0.0% of the portfolio
Largest institutional holders of ANIX
- VANGUARD GROUP INC — $4.55M
- VANGUARD CAPITAL MANAGEMENT LLC — $3.72M
- UBS Group AG (UBS) — $1.64M
- Laird Norton Wetherby Trust Company, LLC — $1.62M
- D.A. DAVIDSON & CO. — $1.51M
- GEODE CAPITAL MANAGEMENT, LLC — $1.01M
- MARSHALL WACE, LLP — $919K
- BlackRock, Inc. (BLK) — $559K
- VANGUARD FIDUCIARY TRUST CO — $539K
- STATE STREET CORP (STT, STT-PG) — $445K
Recent ANIX insider trades
- Oct 22, 2026: Kumar Amit bought 8,000 shares ($21.8K)
- Sep 30, 2026: Catelani Michael bought 5,500 shares ($15.6K)
- Sep 24, 2026: Baskies Arnold M bought 5,000 shares ($13.8K)
- Sep 24, 2026: Kumar Amit bought 7,000 shares ($19.5K)
5%+ owners
- Amit Kumar: 16.3% (Schedule 13D/A, filed Jun 6, 2025)
- Michael Catelani: 7.0% (Schedule 13D/A, filed Jan 6, 2026)
Who owns the most ANIX stock?
The largest institutional holders of Anixa Biosciences Inc in the latest 13F filings are VANGUARD GROUP INC ($4.55M), VANGUARD CAPITAL MANAGEMENT LLC ($3.72M), UBS Group AG (UBS) ($1.64M).
Are insiders buying or selling ANIX?
Over the last 12 months insiders bought $482K and sold $0 of Anixa Biosciences Inc stock on the open market (SEC Form 4).
Which famous investors own ANIX?
Renaissance Technologies, Ken Griffin.